To equitably advance precision medicine at UCSF and beyond by sharing information and fostering connections across dispersed parts of the university; identifying priorities, challenges, and opportunities; and working to advance key precision medicine programs and initiatives.
As UCSF’s first vice chancellor for Science Policy and Strategy, Keith Yamamoto leads efforts to anticipate the needs of an increasingly dynamic biomedical research endeavor, and to position UCSF optimally, by working within the University as well as influencing and shaping science policy at the state and national levels and beyond.
Professor of Medicine; Michelle M. Friend Endowed Chair in Diabetes Research / Diabetes Center
EDUCATION/CLINICAL TRAINING
MD: MD, PhD, University of Chicago, 1994
Residency: University of Minnesota, MD, Internal Medicine, 1994-1997
Chief Resident, University of Minnesota 1997-1998
Fellowship: Massachusetts General Hospital, Adult Endocrinology, 1998-2001
Board Certification: Endocrinology and Metabolism, 2001, Renewed 2012
President, UCSF Helen Diller Family Comprehensive Cancer Center
Senior Vice President for Cancer Services, UCSF Health
Program Lead: Precision Cancer Medicine
Medicine
Alan Ashworth, PhD, FRS, is President of the UCSF Helen Diller Family Comprehensive Cancer Center, and Sr. Vice President for Cancer Services with UCSF Health. Prior to joining UCSF in January 2015, he served as Chief Executive of the Institute of Cancer Research (ICR) and the Director of the Breakthrough Breast Cancer Research Centre in London, United Kingdom.
Professor and Chair of the Department of Epidemiology and Biostatistics
Vice Dean for Population Health and Health Equity, School of Medicine
Program Lead: Precision Population Health
Epidemiology & Biostatistics
Kirsten Bibbins-Domingo, PhD, MD, MAS is the Lee Goldman, MD Endowed Professor of Medicine and Professor of Epidemiology and Biostatistics. She is currently the 17th Editor in Chief of the Journal of the American Medical Association (JAMA) and the JAMA Network.
Dr. Michael Blum is the Associate Vice Chancellor for Informatics and the Chief Digital Transformation Officer at the University of California, San Francisco. Dr. Blum is responsible for UCSF’s strategic design and implementation of informatics and digital health capabilities in support of clinical care delivery and discovery. He is also a Professor of Medicine in Cardiology, specializing in preventative cardiology and the care of patients with congestive heart failure, valvular heart disease, and general cardiology. Dr.
Riley’s first academic passion was anthropology, which she pursued at Harvard College (Phi Beta Kappa), and through a Fulbright grant in Mali. She obtained her MD from Harvard Medical School in 2007, completed her residency in the combined Massachusetts General Hospital – Brigham and Women’s Hospital Neurology program, a clinical research fellowship at the Partners MS Center, and a Masters Degree through Harvard Medical School’s Clinical Investigator Training Program. She has received research support from the NIH and the National MS Society, among others.
Asthma is the most common chronic disease among children affecting Puerto Rican and African American children more than other races/ethnicities. We study the interplay between genes and the environment to determine the root causes of asthma health disparities in children and adolescents to identify and develop targeted interventions to improve asthma outcomes. The complexities of asthma and respiratory disease require a multi-disciplinary approach.
Director of the Bakar Computational Health Sciences Institute
Professor of Pediatrics
Element Lead:Computational Health Sciences
Pediatrics
Atul Butte, MD, PhD is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and inaugural Director of the Bakar Computational Health Sciences Institute (bchsi.ucsf.edu) at the University of California, San Francisco (UCSF). Dr. Butte is also the Chief Data Scientist for the entire University of California Health System, with 20 health professional schools, 6 medical centers, and 10 hospitals. Dr.
My program of research focuses on precision medicine and risk for type 2 diabetes in high risk racial groups. Specifically, I am studying the utility of epigenetic biomarkers for risk detection and prediction of response to risk-reduction interventions. Current studies include investigation of microRNA expression in individuals who are insulin resistant, and prediction of response to both pharmacologic and non-pharmacologic interventions.
Professor of Bioengineering and Therapeutic Sciences
Dean's Office
The Giacomini research group focuses on expanding our understanding of membrane transporters. Membrane transporters are of great biological and pharmacological importance, as they play a major role in human physiology and in drug disposition and response. Major questions addressed in the laboratory include: What is the function of orphan membrane transporters? What is the in vivo role of membrane transporters in the disposition of endogenous solutes as well as in drug disposition and response?
Angela serves as Executive Assistant to Keith R. Yamamoto, PhD and assists with special projects in the Office of the Vice Chancellor for Science Policy and Strategy, working closely with Ben Rubin, Associate Director, Precision Medicine. Angela began her UC career at the University Office of the President, and had a contract position in the University of California San Francisco Office of the Chancellor. Her background is in client communications, marketing, and project management in the tech and financial services industries.
